Suppr超能文献

术中血管加压素在游离空肠瓣重建术中的安全性。

Safety of intra-operative vasopressor in free jejunal flap reconstruction.

机构信息

Division of Head and Neck Surgery, Department of Surgery, University of Hong Kong Li Ka Shing Faculty of Medicine, Queen Mary Hospital, Hong Kong, China.

出版信息

Microsurgery. 2013 Jul;33(5):358-61. doi: 10.1002/micr.22097. Epub 2013 May 24.

Abstract

BACKGROUND

Microvascular surgeons always hold strong belief against the use of vasopressors during free flap surgery. Our aim is to study the safety of intra-operative vasopressors on free jejunal flap reconstruction.

METHODS

A retrospective chart review was performed on patients undergoing free jejunal flap reconstruction, aiming at investigating the intra-operative use of vasopressors and the potential complications associated.

RESULTS

Between 1984 and 2012, 110 free jejunal flaps were performed for reconstruction of circumferential pharyngeal defects created after resection of cancers of the hypopharynx. Intra-operative vasopressor was given in 81 (73.6%) patients. The most common vasopressors used were ephedrine (42.7%), phenylephrine (14.5%) or both (42.8%). They were administered to the patients before the start of flap harvesting (n = 32, 29.1%), during the flap harvesting (n = 30, 27.3%), during microvascular anastomosis (n = 20, 18.2%), or they were given more than once during the whole operation (n = 28, 25.4%). The incidence of intra-operative re-anastomosis due to thrombosis was 4.5% and the post-operative flap failure rate was 5.4%. There was no significant relationship between the administration of vasopressor during surgery and the need for intra-operative re-anastomosis, post-operative flap failure and the timing of flap failure. Similarly, there was also no relationship between the timing of vasopressor administration and the above variables. The long-term stricture rate was 2.7%, the risk of which was not increased by the intra-operative use of vasopressors.

CONCLUSION

The intra-operative use of vasopressors is safe in free jejunal flap reconstruction.

摘要

背景

微血管外科医生一直强烈反对在游离皮瓣手术中使用血管加压药。我们的目的是研究术中使用血管加压药对游离空肠瓣重建的安全性。

方法

对接受游离空肠瓣重建的患者进行回顾性图表审查,旨在调查术中使用血管加压药的情况及其相关的潜在并发症。

结果

1984 年至 2012 年间,为重建下咽癌切除后环形咽缺损,共进行了 110 例游离空肠瓣重建。81 例(73.6%)患者术中给予血管加压药。最常用的血管加压药是麻黄碱(42.7%)、苯肾上腺素(14.5%)或两者合用(42.8%)。它们在皮瓣采集前(n=32,29.1%)、皮瓣采集过程中(n=30,27.3%)、微血管吻合过程中(n=20,18.2%)或整个手术过程中多次给药(n=28,25.4%)。由于血栓形成而需要术中再次吻合的发生率为 4.5%,术后皮瓣失败率为 5.4%。术中给予血管加压药与术中再次吻合、术后皮瓣失败以及皮瓣失败的时间之间无显著关系。同样,血管加压药的给药时间与上述变量之间也没有关系。长期狭窄率为 2.7%,术中使用血管加压药并未增加其风险。

结论

在游离空肠瓣重建中,术中使用血管加压药是安全的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验